154 related articles for article (PubMed ID: 835136)
41. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
Adamson U; Cerasi E
Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
[TBL] [Abstract][Full Text] [Related]
42. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes.
Damm P; Kühl C; Hornnes P; Mølsted-Pedersen L
Diabetes Care; 1995 May; 18(5):654-65. PubMed ID: 8586003
[TBL] [Abstract][Full Text] [Related]
43. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
[TBL] [Abstract][Full Text] [Related]
44. Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response?
Cerasi E; Luft R
Acta Endocrinol (Copenh); 1967 Jun; 55(2):330-45. PubMed ID: 5338208
[No Abstract] [Full Text] [Related]
45. Insulin responses of children with chemical diabetes mellitus.
Rosenbloom AL
N Engl J Med; 1970 May; 282(22):1228-31. PubMed ID: 5442631
[No Abstract] [Full Text] [Related]
46. The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels.
Holdsworth CD; Nye L; King E
Gut; 1972 Jan; 13(1):58-63. PubMed ID: 5060671
[TBL] [Abstract][Full Text] [Related]
47. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
[TBL] [Abstract][Full Text] [Related]
48. [Early diagnosis of diabetic disease].
Sensi S
Minerva Med; 1973 Sep; 64(62):3219-49. PubMed ID: 4775165
[No Abstract] [Full Text] [Related]
49. The intravenous tolbutamide test in diagnosing mild and latent diabetes mellitus.
Andersen OO; Friis T
Acta Med Scand; 1967 May; 181(5):535-45. PubMed ID: 6025702
[No Abstract] [Full Text] [Related]
50. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
[TBL] [Abstract][Full Text] [Related]
51. Changes in plasma insulin and glucose tolerance in stable diabetes in a young woman.
Kosaka K; Hagura R; Saito R; Tsukamoto F; Kuzuya T
Diabetes; 1969 Jul; 18(7):487-92. PubMed ID: 5795031
[No Abstract] [Full Text] [Related]
52. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
[TBL] [Abstract][Full Text] [Related]
53. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
Bohannon NV; Lorenzi M; Grodsky GM; Karam JH
J Clin Endocrinol Metab; 1982 Feb; 54(2):459-62. PubMed ID: 7054228
[TBL] [Abstract][Full Text] [Related]
54. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
55. [Diabetes mellitus. 3. Diagnosis of diabetes mellitus].
Hildmann W; Schliack V; Honigmann G; Bibergeil H
Z Arztl Fortbild (Jena); 1970 Jan; 64(1):25-31. PubMed ID: 5420869
[No Abstract] [Full Text] [Related]
56. Subclinical Diabetes.
Lima LMTR
An Acad Bras Cienc; 2017 May; 89(1 Suppl 0):591-614. PubMed ID: 28492735
[TBL] [Abstract][Full Text] [Related]
57. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range.
Kosaka K; Hagura R; Kuzuya T; Kuzuya N
Diabetologia; 1974 Dec; 10(6):775-82. PubMed ID: 4442669
[No Abstract] [Full Text] [Related]
58. Plasma insulin response to various secretagogues in insulinoma.
Ohneda A; Kobayashi T; Nihei J
Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
[TBL] [Abstract][Full Text] [Related]
59. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
Hussein MS; Abushady MM; Refaat S; Ibrahim R
Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
[TBL] [Abstract][Full Text] [Related]
60. [Behavior of the serum I.R.I. in persons with latent diabetes after endovenous tolbutamide load].
Artenisio AC; Albanese MC; Allegra V; Alibrando S; Caruso A; Sprovieri M; Corsi V
Folia Endocrinol; 1972 Aug; 25(4):300-11. PubMed ID: 4678219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
